Y Hu, AY Liu, L Zhang, X Wu, S Shi… - Journal of Vascular …, 2019 - europepmc.org
Objective The direct thrombin inhibitor bivalirudin (BIV) was shown to be superior to unfractionated heparin (UFH) in percutaneous coronary interventions for reducing …
Y Hu, AY Liu, L Zhang, X Wu, S Shi… - Journal of Vascular …, 2019 - jvascsurg.org
Objective The direct thrombin inhibitor bivalirudin (BIV) was shown to be superior to unfractionated heparin (UFH) in percutaneous coronary interventions for reducing …
Y Hu, AY Liu, L Zhang, X Wu, S Shi… - Journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Objective The direct thrombin inhibitor bivalirudin (BIV) was shown to be superior to unfractionated heparin (UFH) in percutaneous coronary interventions for reducing …